Home  /  Resource Library  /  Real-world comparative effectiveness of first-line BTK inhibitors in chronic lymphocytic leukemia

Real-world comparative effectiveness of first-line BTK inhibitors in chronic lymphocytic leukemia

Real world study comparing acalabrutinib and zanubrutinib for first line treatment of CLL.